Literature DB >> 15105046

G2-M arrest and antimitotic activity mediated by casticin, a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.).

Junko Kobayakawa1, Fumiko Sato-Nishimori, Masataka Moriyasu, Yoshizumi Matsukawa.   

Abstract

Flavonoids are distributed in many plants. We studied the antitumor effects of flavonoids isolated from Viticis Fructus, casticin, artemetin, quercetagetin and 5,3'-dihydroxy-6,7,4' -trimethoxyflavanone. Casticin inhibited the growth of KB cells markedly (IC(50)=0.23 microM), compared with the other flavonoids tested (IC(50)=15.3-18.6 microM). In contrast, casticin did not inhibit the proliferation of A431 cells similar to normal cell lines, 3T3 Swiss Albino and TIG-103. Flow cytometric analyses revealed that the exposure of KB cells to casticin led to significant arrest at G2-M. In immunostaining of KB cells, casticin disrupted mitotic spindles. These results suggest that G2-M arrest by casticin may be relevant to its antimitotic activity, although the mechanism of selective growth inhibition has been unknown. Further examinations are required to confirm that casticin is an antitumor drug for specific cancers with low toxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105046     DOI: 10.1016/j.canlet.2004.01.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells.

Authors:  Jun Yang; Yun Yang; Li Tian; Xi-Feng Sheng; Fei Liu; Jian-Guo Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

2.  The Systemic Theory of Living Systems. Part IV: Systemic Medicine--The Praxis.

Authors:  José A Olalde Rangel; Meyer Magarici; Francis Amendola; Oswaldo del Castillo
Journal:  Evid Based Complement Alternat Med       Date:  2005-12       Impact factor: 2.629

3.  Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist.

Authors:  Meng He; Xiao-Cheng Cao; Gui-Cheng He; Xi-Feng Sheng; Xiao-Hong Ai; You-Hua Wu
Journal:  Oncol Lett       Date:  2014-02-21       Impact factor: 2.967

4.  SRVF, a novel herbal formula including Scrophulariae Radix and Viticis Fructus, disrupts focal adhesion and causes detachment-induced apoptosis in malignant cancer cells.

Authors:  Aeyung Kim; Minju Im; Jin Yeul Ma
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

5.  Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway.

Authors:  Ling Zhou; Xiaoying Dong; Linlin Wang; Lanlan Shan; Ting Li; Wanfu Xu; Yan Ding; Mingqiang Lai; Xiaojun Lin; Meng Dai; Xiaochun Bai; Chunhong Jia; Hang Zheng
Journal:  Oncotarget       Date:  2017-04-27

6.  Vitexicarpin acts as a novel angiogenesis inhibitor and its target network.

Authors:  Bo Zhang; Lu Liu; Shiwen Zhao; Xu Wang; Liyang Liu; Shao Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-12       Impact factor: 2.629

7.  Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress.

Authors:  Yuan Zhou; Li Tian; Lingzhi Long; Meifang Quan; Fei Liu; Jianguo Cao
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

8.  Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.

Authors:  Vasilis Androutsopoulos; Randolph R J Arroo; John F Hall; Somchaiya Surichan; Gerry A Potter
Journal:  Breast Cancer Res       Date:  2008-05-02       Impact factor: 6.466

Review 9.  The genus Vitex: A review.

Authors:  Anita Rani; Anupam Sharma
Journal:  Pharmacogn Rev       Date:  2013-07

10.  Casticin inhibits self-renewal of liver cancer stem cells from the MHCC97 cell line.

Authors:  Guicheng He; Xiaocheng Cao; Meng He; Xifeng Sheng; Youhua Wu; Xiaohong Ai
Journal:  Oncol Lett       Date:  2014-03-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.